Sign In
Buy APYX
$3.79
-0.0600 (-1.56%)
At Close: Jun 03, 2026
Apyx Medical Corp (APYX) Q1 2020 Earnings Call Transcript
08:31am, Tuesday, 12'th May 2020
Image source: The Motley Fool. Apyx Medical Corp (NASDAQ: APYX)Q1 2020 Earnings CallMay 11, 2020, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:
Apyx Medical (APYX) Reports Q1 Loss, Misses Revenue Estimates
12:55pm, Monday, 11'th May 2020
Apyx (APYX) delivered earnings and revenue surprises of 72.73% and -5.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical: Q1 Earnings Insights
12:10pm, Monday, 11'th May 2020
Shares of Apyx Medical (NASDAQ:APYX) were flat in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share fell 42.86% over the past year to ($0.20), which beat th
Apyx Medical Corporation Reports First Quarter 2020 Financial Results
11:00am, Monday, 11'th May 2020
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery m
Apyx Medical Corporation Reports First Quarter 2020 Financial Results
12:00am, Monday, 11'th May 2020
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, markete
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
12:00am, Friday, 08'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 7)
• Acceleron Pharma Inc (...
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Update in Lawsuit against Apyx Medical Corporation (NASDAQ: APYX) announced by Shareholders Foundation
11:10am, Monday, 04'th May 2020
On April 17, 2019, a lawsuit was filed against Apyx Medical Corporation /k/a/ Bovie Medical Corporation over alleged Securities Laws Violations. The plaintiff alleges that the Defendants made false a
LOS ANGELES, CA / ACCESSWIRE / April 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Cor
PHILADELPHIA, PA / ACCESSWIRE / April 20, 2020 / Kaskela Law LLC is investigating Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) on behalf of the Company's investors. ...
Johnson Fistel, LLP is investigating potential claims on behalf of Apyx Medical Corporation (formerly Bovie Medical) ("Apyx" or the "Company") (APYX) against certain of its officers and directors. I
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Apyx Medical Corpo
Apyx Medical Corp (NASDAQ:APYX) Short Interest Update
07:18am, Thursday, 16'th Apr 2020
Apyx Medical Corp (NASDAQ:APYX) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 527,200 shares, a decrease of 44
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Corporation ("Apyx" or "the Company") (NASDAQ:APYX)
